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The pseudophosphatase MK-STYX (mitogen-activated protein kinase phos-
phoserine/threonine/tyrosine-binding protein) has been implicated in the
stress response pathway. The expression of MK-STYX inhibits the assem-
bly of stress granules, which are cytoplasmic storage sites for mRNA that
form as a protective mechanism against stressors such as heat shock, UV
irradiation and hypoxia. Furthermore, MK-STYX interacts with a key
component of stress granules: G3BP-1 (Ras-GTPase activating protein SH3
domain binding protein-1). Because G3BP-1 dephosphorylation at Ser149
induces stress granule assembly, we initially hypothesized that the inhibition
of stress granules by MK-STYX was G3BP-1 phosphorylation-dependent.
However, in the present study, using MK-STYX constructs and G3BP-1
phosphomimetic or nonphosphorylatable mutants, we show that MK-
STYX inhibits stress granule formation independently of G3BP-1 phos-
phorylation at Ser149. The introduction of point mutations at the ‘active
site’ of MK-STYX that convert serine and phenylalanine to histidine and
cysteine, respectively, is sufficient to generate an active enzyme. In separate
experiments, we show that this active mutant, MK-STYXactive, has opposite
effects to wild-type MK-STYK. Not only does MK-STYXactive induce stress
granules, but also it has the capacity to dephosphorylate G3BP-1. Taken
together, these results provide evidence that the pseudophosphatase
MK-STYX plays a key role in the cellular response to stress.
Introduction
Protein phosphorylation signalling cascades regulate
many diverse cellular responses, including the stress
response. Kinases and phosphatases control the activity
of target proteins by coordinating a fine balance
between phosphorylation and dephosphorylation.
Disruption of this balance leads to diseases such as can-
cer, diabetes, chronic inflammation and Alzheimer’s. In
a newly recognized level of complexity, phosphoryla-
tion cascades are further modulated by a variety of
pseudokinases and pseudophosphatases [1–5], which
lack catalytic activity but have homology to kinases
and phosphatases, respectively. An intriguing advance
in the field was the discovery of naturally existing ‘sub-
strate-trapping mutants’. In these mutants, an inactive
version of the catalytic domain converts extremely
active protein tyrosine phosphatases (PTPs) into sub-
strate traps [6]. Over the past 15 years, the development
of synthetic ‘substrate-trapping’ mutants has helped
Abbreviations
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identify many PTP substrates and advanced our under-
standing of the physiological roles of PTPs. However, it
remains equally important to characterize the function
of naturally-occurring pseudophosphatases, which also
have the ability to bind phosphorylated residues [4,5].
Many pseudophosphatases have been identified [7],
yet the function of most of these catalytically-dead
members of the PTP family remains elusive. Other
members of the PTP family have an active site signature
motif [3], in which a nucleophilic cysteine is essential
for catalytic activity. However, pseudophosphatases
lack critical residues within their active site, preventing
enzymatic activity [5]. Reports have shown that a single
point mutation that converts a substituted amino acid
in the active site back to a cysteine restores enzymatic
activity [1,4]. In addition, the classical PTP fold is pre-
served in pseudophosphatases, thus maintaining their
ability to bind phosphorylated target proteins [6,8,9].
Initially, it was proposed that these proteins would
serve as naturally-occurring substrate-trapping mutants
that block the function of endogenous phosphatases [7].
However, the prototypic pseudophosphatase STYX
(phosphoserine/threonine/tyrosine-binding protein),
which has a glycine residue instead of cysteine in its
active site [4,5], interacts with the RNA-binding protein
CRHSP24 (calcium-responsive heat-stable protein with
a molecular mass of 24 kDa) [10]. Furthermore, the
interaction of STYX with CRHSP24 is essential for
spermatogenesis in mice [10]. Besides STYX, a number
of pseudophosphatases may regulate signalling cascades
[7,11,12] in ways other than by merely preventing
dephosphorylation of target phosphate groups. For
example, some pseudophosphatases engage in direct
protein–protein interactions rather than protein–phos-
phate binding interactions with their target proteins [7].
To date, the myotubularin (MTM) family is the most
prevalent group of pseudophosphatases involved in
such interactions. For example, the pseudophosphatase
MTM-2 forms a complex with its active homologue
MTM-13, and MTM-2 also regulates the function and
subcellular localization of the active phosphatase [13].
Furthermore, a mutation in either protein in a MTM
pseudophosphatase–phosphatase complex such as
MTM-13 or MTM-2 results in Charcot–Marie–Tooth
disease, which is characterized by abnormal nerve mye-
lination [14]. Pseudophosphatases not only interact
with phosphatases, but also form complexes with kinas-
es to regulate their activity [7,12,15]. In particular, the
Caenorhabditis elegans pseudophosphatases EGG-4
and EGG-5 inhibit the activity of the dual-specificity
tyrosine-regulated kinase minibrain kinase homologue-
2 (MBK-2) by binding to its activation loop, preventing
substrate phosphorylation [7,15].
In the present study, we focus on the pseudophos-
phatase MK-STYX, a member of the mitogen-acti-
vated protein kinase (MAPK) phosphatase class
[1,3,5]. Whereas catalytically active phosphatases
include the signature motif HC(X5)R, the correspond-
ing MK-STYX sequence (IFSTQGISRS) lacks both
the critical histidine and cysteine residues [1,3,16]. As
in other cases, mutations that restore this signature
motif, IHCTQGISRS, create an active phosphatase [1].
In its native, catalytically-inactive form, wild-type
MK-STYX functions in a number of important cellu-
lar pathways. Conversely, alterations in MK-STYX
expression are associated with tumorigenesis; for
example, MK-STYX is highly expressed in Ewing’s
sarcoma cells [17].
In earlier studies concerning the cellular functions of
MK-STYX, we discovered that MK-STYX binds
directly to a protein that regulates both the Ras signal-
ling pathway and stress granule assembly [1]. This reg-
ulator, G3BP-1 (Ras-GTPase activating protein SH3
domain binding protein-1), is ubiquitously expressed
and contains several distinct domains that enable it to
interact with multiple protein and RNA-binding part-
ners [18,19]. Furthermore, G3BP-1 is also widely
accepted as a marker and nucleator of stress granules
[20,21]. In particular, studies of G3BP-1 and/or vari-
ous G3BP-1 mutants have revealed important insights
into the dynamic assembly of stress granules [22–25].
Although G3BP-1 has multiple phosphorylation sites,
only Ser149 is considered to be significant for stress
granule assembly [23]. Specifically, mammalian cells
expressing either G3BP-1 or a nonphosphorylatable
G3BP-1 mutant (S149A) induce stress granule assem-
bly, whereas the phosphomimetic mutant (S149E) does
not induce stress granule assembly [23].
The present study focuses on understanding how
MK-STYX inhibits stress granule formation. Initially,
we hypothesized that MK-STYX inhibited stress gran-
ule formation by locking G3BP-1 in its phosphorylated
state. However, in the present study, we show that, in
heat-shocked HeLa cells, the expression of MK-STYX
significantly inhibits stress granule formation in the
presence of either phosphomimetic (S149E) or non-
phosphorylatable (S149A) G3BP-1 mutants. These data
indicate that MK-STYX inhibits stress granule forma-
tion independently of the phosphorylation state of
G3BP-1 at Ser149, and thus suggest that MK-STYX
acts at another point in the signalling pathway. Never-
theless, an interaction between MK-STYX and G3BP-1
is supported both by our immunoprecipitation studies
[1], as well as by the observation that the catalytically-
active mutant of MK-STYX was able to dephos-
phorylate G3BP-1 specifically at Ser149 and induce
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endogenous stress granules. Furthermore, the presence
of the active mutant induced the formation of stress
granules by the phosphomimetic G3BP-1 mutant
(S149E), as well as larger granules in the presence of
S149A-G3BP. Taken together, these data provide evi-
dence for a role of MK-STYX as a regulator in the
stress response pathway.
Results
MK-STYX inhibits G3BP-1-induced stress granule
formation
Stress granule assembly can be induced by a variety of
stressors, including the overexpression of G3BP-1 and
the dephosphorylation of G3BP-1 at Ser149 [23]. Con-
versely, stress granule assembly can be blocked by the
overexpression of MK-STYX [1]. To test whether
MK-STYX could inhibit stress granule formation
induced by phosphomimetic and nonphosphorylatable
mutants of G3BP-1, we first needed to establish a
baseline for analyzing changes in the pattern of stress
granule assembly for wild-type G3BP-1. Accordingly,
we expressed wild-type green fluorescent protein
(GFP)-tagged G3BP-1 either alone, or together with
wild-type FLAG-tagged MK-STYX or the catalyti-
cally active mutant of MK-STYX (MK-STYXactive)
(Fig. 1). As anticipated from our previous studies [1],
G3BP-1 overexpression induced the formation of large,
perinuclear stress granules, whereas stress granule for-
mation was markedly inhibited by the co-expression
of MK-STYX. By contrast, the co-expression of
MK-STYXactive induced the formation of intermediate
granules (smaller aggregates dispersed throughout the
cytoplasm). Because we had previously shown that
MK-STYX does not suppress the expression of G3BP-1
[1], this inhibition of stress granule formation is not
the result of a lack of G3BP-1 expression.
Inhibition of stress granule assembly by
MK-STYX is independent of phosphorylation
of G3BP-1 at Ser149
Dephosphorylation of G3BP-1 at Ser149 has been
shown to induce stress granule assembly [23]. To deter-
mine whether the ability of MK-STYX to inhibit stress
granule assembly requires phosphorylation of G3BP-1
at Ser149, we co-expressed either the wild-type or
active mutant form of MK-STYX with GFP-tagged
versions of either S149A-G3BP or S149E-G3BP
(Fig. 2). Consistent with earlier studies [23], the
expression of nonphosphorylatable S149A-G3BP alone
resulted in stress granule assembly in  60% of the
transfected cells (Fig. 2A,B), whereas the expression of
the phosphomimetic S149E-G3BP alone was associ-
ated with low levels of stress granule assembly
(< 20%) (Fig. 2D).
To determine how the pseudophosphatase MK-
STYX might alter these levels, we co-expressed the
S149A-G3BP mutant with MK-STYX. Based on our
initial model, we predicted that MK-STYX would
inhibit stress granule formation by shielding the phos-
phate group at Ser149 of G3BP-1 from phosphatase
activity; hence, the expression of MK-STYX was not
expected to alter stress granule formation. However,
when we measured stress granule formation in cells
Fig. 1. MK-STYX inhibits G3BP-1 induced stress granules. (A) Representative examples of the subcellular distribution patterns of G3BP-1.
HeLa cells cotransfected with expression vectors for G3BP-1 and wild-type MK-STYX showed fewer cells with stress granules.
Overexpression of G3BP-1 and MK-STYX active mutant resulted in intermediate stress granule assembly. Merged images show the location
of GFP-tagged G3BP-1 (green) relative to DAPI-stained nuclei (blue). Scale bar = 10 lm. (B) HeLa cells were cotransfected with expression
vectors for G3BP1-GFP and either MK-STYX or MK-STYX active mutant. Cells were analyzed 24 h post-transfection for G3BP-induced stress
granule assembly by fluorescence microscopy, after staining with DAPI to reveal the nuclei. Cells were scored for the presence or absence
of stress granules. Three replicate experiments were performed (n = 100); error bars indicate the SEM.
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co-expressingMK-STYX and S149A-G3BP,MK-STYX
was found to suppress stress granule assembly (Fig. 2A,
B). This unexpected result indicates that the ability of
MK-STYX to inhibit stress granule assembly does not
solely depend on the phosphorylation state of G3BP-1 at
residue 149.
Given the inhibitory effect of MK-STYX, we next
tested whether the expression of the phosphatase-active
mutant of MK-STYX (MK-STYXactive) would
enhance stress granule formation in cells co-expressing
either the nonphosphorylatable or phosphomimetic
G3BP-1 mutants. In the presence of MK-STYXactive,
not only did cells expressing the nonphosphorylatable
S149A-G3BP mutant form stress granules (Fig. 2B),
but also the stress granules that formed were nota-
bly larger (Fig. 2A). Furthermore, co-expression of
MK-STYXactive with the phosphomimetic S149E-
G3BP mutant resulted in more cells with stress gran-
ules overall and stress granules that were intermediate
in size (Fig. 2C), consistent with studies of wild-type
G3BP-1 (Fig. 1A,B) [1]. Overall,  53% of cells
expressing the phosphomimetic S149E-G3BP and MK-
STYXactive formed stress granules (Fig. 2C,D). The
additive effect of larger stress granules forming in the
presence of the active mutant of MK-STYX may sug-
gest an interaction between MK-STYX and microtu-
bules. Previous studies have suggested that larger
aggregates form when microtubules transport smaller
aggregates to a localized area [26–28]. In our studies,
the induction of larger granules in cells co-expressing
the active mutant and nonphosphorylatable S149A-
G3BP suggests that the active mutant may initiate
and/or facilitate the transport of smaller aggregates to
a localized area.
Transient overexpression of the stress granule-asso-
ciated protein G3BP-1 is a commonly used approach
for investigating stress granule assembly because it
results in the appearance of stress granules in the
Fig. 2. Phosphorylation-independent inhibition of stress granule assembly by MK-STYX. (A, C) Representative examples of the subcellular
distribution patterns of GFP-tagged G3BP-149 mutants. HeLa cells cotransfected with expression vectors for S149A-G3BP and wild-type
MK-STYX showed fewer cells with stress granules. The overexpression of S149A-G3BP alone resulted in stress granule assembly. Cells
cotransfected with S149A-G3BP and the active MK-STYX mutant accumulated larger perinuclear granules. Cells expressing S149E-G3BP
mutant alone or in the presence of MK-STYX did not accumulate stress granules, whereas cells expressing S149E-G3BP and the MK-STYX
active mutant accumulated smaller granules that were more dispersed throughout the cytoplasm. Merged images show the location of
GFP-tagged G3BP-1 mutants (green) relative to DAPI-stained nuclei (blue). Scale bar = 10 lm. (B, D) HeLa cells were cotransfected with
expression vectors for GFP-tagged G3BP-149 mutants, and either MK-STYX or MK-STYX active mutant. Cells were analyzed 24 h post-
transfection for G3BP-induced stress granule assembly by fluorescence microscopy, after staining DAPI to reveal the nuclei. Cells were
scored for the presence or absence of stress granules. Three replicate experiments were performed (n = 100); error bars indicate the SEM.
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absence of external stressors [29]. However, in some
cases, when mutant forms of G3BP-1 are being investi-
gated, external stressors must be used to induce stress
granule formation [29]. Thus, to investigate the effects
of MK-STYX on the G3BP-1 phosphomimetic
mutant, we heat-shocked cells expressing the phosp-
homimetic S149E-G3BP mutant together with either
MK-STYX or MK-STYXactive (Fig. 3). As expected,
we observed fewer cells with stress granules under both
the nonheat-shocked conditions (Fig. 3A) and in cells
expressing MK-STYX under heat-shocked conditions
(Fig. 3C). Once again, the active mutant induced inter-
mediate stress granule formation in unstressed cells
that were also expressing the phosphomimetic S149E-
G3BP-1 mutant (Fig. 3A). Approximately 55% of heat
shock-stimulated cells expressing S149E-G3BP formed
stress granules (Fig. 3B,C). These data are consistent
with a previous study demonstrating that, in the pres-
ence of S149E-G3BP, arsenite-stressed Cos cells
formed stress granules [23]. Although heat shock
induced the formation of stress granules in cells
expressing S149E-G3BP, co-expression of MK-STYX
prevented their formation (Fig. 3B,C). Thus, the inter-
action between the G3BP-1 mutants and MK-STYX
may elicit a conformational change in G3BP-1 that
prevents stress granule formation. Taken together,
these results imply that the mechanism by which the
pseudophosphatase MK-STYX prevents stress granule
formation involves complexities beyond protecting
G3BP-1 at phospho-S149.
Expression of the active mutant of MK-STYX
induces stress granule formation
Because MK-STYXactive induced stress granules in the
presence of the G3BP-1 phosphomimetic mutant, we
Fig. 3. Induction of S149E-G3BP stress granule assembly by the MK-STYX active mutant. Representative examples of the subcellular
distribution of GFP-tagged S149E-G3BP without heat shock (A) or after heat shock at 41 °C (B), in the presence of pMT2 (empty vector),
MK-STYX or the active mutant as indicated. Cells were fixed, stained with DAPI and analyzed 24 h post-transfection for heat shock-induced
stress granule assembly by fluorescence microscopy. Merged images show the localization of S149E-G3BP (green) relative to the DAPI-
stained nucleus (blue). Scale bar = 10 lm. (C) Cells were scored for the presence or absence of stress granules. Three replicate
experiments were performed (n = 100 cells for each experiment); error bars indicate the SEM.
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aimed to determine whether expression of the active
mutant alone could induce endogenous stress gran-
ules. We compared the effects of heat shock on stress
granule formation in cells transfected with either
empty vector as a control, or MK-STYX or
MK-STYXactive expression plasmids. Endogenous
G3BP-1, a nucleator of stress granules [23], was used
as the marker for stress granule formation. The expres-
sion of endogenous G3BP-1 was visualized by indirect
immunofluorescence with antibodies specific for
G3BP-1 (Fig. 4). Heat shock induced stress granule
formation in ~50% of the control cells. As expected,
the expression of MK-STYX significantly suppressed
stress granule formation; only  15% of cells ectopi-
cally expressing MK-STYX formed granules (Fig. 4B,
C). By contrast, MK-STYXactive promoted the forma-
tion of stress granules in both nonstimulated and
heat-shocked cells (Fig. 4A–C). Expression of both
FLAG-tagged MK-STYX and the active mutant was
detected in cell lysates with anti-FLAG sera (Fig. 4D).
To test whether MK-STYX co-localizes with G3BP-1,
we double-stained cells by indirect immunofluores-
cence using anti-G3BP-1 and anti-FLAG sera. We
compared cells expressing MK-STYX with cells
expressing MK-STYXactive and scored only the cells
expressing MK-STYX or MK-STYXactive for stress
granule formation (Fig. 4E). Approximately 23% of
cells expressing the active mutant assembled stress
granules, whereas MK-STYX was comparable to the
control (Fig. 4F). Furthermore, MK-STYXactive co-
localized with endogenous G3BP-1 to a greater extent
than MK-STYX (Fig. 4E), suggesting that the active
mutant may dephosphorylate MK-STYX.
MK-STYXactive dephosphorylates G3BP-1 at
Ser149
The observation that MK-STYXactive induces stress
granules and colocalizes with endogenous G3BP-1 sug-
gested that this catalytically active form might directly
dephosphorylate G3BP-1. To specifically test this
point, 32P-labelled endogenous G3BP-1 and ectopically
expressed GFP-tagged G3BP-1 were immunopre-
cipitated and used as substrates (Fig. 5). Immuno-
precipitated MK-STYXactive dephosphorylated both
endogenous G3BP-1 (Fig. 5A) and ectopically
expressed GFP-tagged G3BP-1 (Fig. 5B). By contrast,
immunoprecipitates of wild-type MK-STYX did not
dephosphorylate either endogenous G3BP-1 or G3BP-
GFP. Both MK-STYX and the active mutant were
detected in immunoprecipitates with anti-FLAG sera
(Fig. 5C), indicating that differences in phosphatase
activity were not a result of altered protein levels.
To determine whether MK-STYXactive specifically
dephosphorylates G3BP-1 at site 149, western blots
were performed with an antibody specific for G3BP-1
phosphorylation at Ser149 [anti-phospho-G3BP
(pSer149)]. In the presence of MK-STYXactive, phosp-
hoG3BP-1 at site 149 was not detectable (Fig. 5D),
suggesting that the active mutant dephosphorylates
MK-STYX. By contrast, phosphoG3BP-1 at site 149
was detectable in the presence of wild-type MK-STYX
(Fig. 5D).
Taken together, our results demonstrate that wild-
type MK-STYX and its active mutant elicit opposite
effects on stress granule formation. Furthermore,
including MK-STYXactive in these studies for compari-
son not only supports, but also strengthens the idea
that pseudophosphatases have specific and important
roles in signalling cascades.
Discussion
The ability of the pseudophosphatase MK-STYX to
inhibit stress granule formation was originally assumed
to depend solely on its interaction with phosphorylated
G3BP-1. However, the data reported in the present
study are inconsistent with this model. Instead, our
studies with MK-STYX constructs and G3BP-1
mutants indicate that MK-STYX may act beyond the
G3BP-1 signalling pathway to regulate stress granule
formation. The results obtained dispel the notion that
MK-STYX inhibits stress granules by simply protect-
ing phosphorylation of G3BP-1 at Ser149. Instead, the
data suggest a new model that takes into account this
more complicated interaction between the pseudophos-
phatase and G3BP-1 (Fig. 6). In summary, the pseudo-
phosphatase MK-STYX inhibits G3BP-1-induced
stress granule formation (Fig. 6A,B,D), whereas the
active mutant, MK-STYXactive, induces stress granule
formation and, in some cases, induces larger stress
granule aggregates (Fig. 6E). Furthermore, the non-
phosphorylatable mutant S149E-G3BP-1 is unable to
induce stress granules (Fig. 6C), except in the presence
of MK-STYXactive, pointing to the importance of a
conformational change in G3BP-1 for aggregation and
stress granule formation. Finally, these studies demon-
strate the importance of comparing a naturally-occur-
ring pseudophosphatase with its mutated catalytically-
active form. In this case, the comparison clearly dem-
onstrates the distinct interaction of the pseudophos-
phatase MK-STYX with G3BP-1; MK-STYX inhibits
stress granule assembly.
Dephosphorylation of G3BP-1 at site 149 is essential
for stress granule assembly [23]; however, the mecha-
nism is not well understood. In the present study, the
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co-expression of MK-STYX and a G3BP-1 non-
phosphorylatable mutant (S149A-G3BP) revealed that
MK-STYX is capable of inhibiting stress granule
assembly independently of G3BP-1 phosphorylation
status at Ser149. Furthermore, the active mutant of
MK-STYX induced stress granules. Although the
mode of action of MK-STYX remains to be
determined, the findings reported in the present study
Fig. 4. Inhibition of heat shock-induced stress granule formation by MK-STYX Representative examples of the subcellular distribution of
endogenous G3BP-1 without heat shock (A) or after heat shock at 41 °C (B), in the presence of pMT2 (empty vector), MK-STYX or the
active mutant as indicated. Cells transfected with MK-STYX did not form heat shock-induced granules, whereas the active mutant induced
granules in the presence or absence of heat shock. Cells were fixed, stained with anti-G3BP and Cy3-conjugated goat anti-mouse sera and
DAPI, and analyzed 24 h post-transfection for heat shock-induced stress granule assembly by fluorescence microscopy. Merged images
show the localization of endogenous G3BP-1 (red) relative to DAPI-stained nuclei (blue). Scale bar = 10 lm. (C) Cells were scored for the
presence or absence of stress granules. Three replicate experiments were performed (n = 100 cells for each experiment); error bars
indicate the SEM. (D) Blots were probed with anti-FLAG to visualize the presence of MK-STYX or active mutant. (E) Representative
examples of the subcellular distribution of endogenous G3BP-1 and MK-STYX or MK-STYXactive. Cells were fixed, stained with anti-G3BP
and Cy3-conjugated goat anti-mouse sera, FLAG conjugated to FITC (anti-FLAG-FITC) for the detection of FLAG-tagged MK-STYX or MK-
STYXactive and DAPI. (F) Cells overexpressing MK-STYX or MK-STYXactive (green) were scored for the presence or absence of stress
granules. Merged images show the localization of endogenous G3BP-1 (red) relative to MK-STYX (green), MK-STYXactive (green) or DAPI-
stained nuclei (blue). Scale bar = 10 lm.
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enhance our understanding of its interaction with
G3BP-1, and provide new insight into the role of
MK-STYX in the stress granule life cycle. In the
broader perspective, our findings point to the possibi-
lity that pseudophosphatases are not simply ‘protec-
tors’ of phosphorylated proteins but, instead, are
important regulators of signalling cascades, including
the stress response pathway.
The finding that wild-type MK-STYX and
MK-STYXactive elicit opposite effects on stress granule
formation is insightful to our understanding of the
molecular mechanism of the pseudophosphatase
MK-STYX. Furthermore, our immunoblotting results
suggest that MK-STYXactive dephosphorylates G3BP-1
at Ser149, indicating the possibility that wild-type
MK-STYX interacts with G3BP-1 at this site. How-
ever, our results demonstrate that phosphorylation of
S149 is not required for MK-STYX to inhibit G3BP-
1-induced stress granule formation. This raises the
question of how MK-STYX might inhibit stress gran-
ule formation. The answer may lie within other key
characteristics of G3BP-1.
G3BP-1 originally was purified in a complex with
RasGAP (Ras GTPase activating protein) [30], which
is essential for Ras signalling. The G3BP–GAP com-
plex only forms in proliferating cells, suggesting that
Ras must be in its activated conformation for G3BP
and RasGAP interaction [30]. Furthermore, the phos-
phorylation pattern of G3BP-1 differs in quiescent
and proliferating cells; it is highly phosphorylated on
multiple serine residues in quiescent cells, although
proliferating cells lack phosphorylation at Ser149 [18].
The absence of a phosphate group on Ser149 in pro-
liferating cells was shown to be dependent on Ras-
GAP, as well as to influence the subcellular
distribution of G3BP-1 [18]. The normally cytosolic
protein translocates to the nucleus when phosphory-
lated at Ser149 [22]. The fact that MK-STYX is a
Fig. 5. MK-STYX active mutant dephosphorylates G3BP-1. HeLa cells or HeLa cells expressing G3BP-1-GFP were labelled with [c-32P]ATP,
lysed and immunoprecipitated with anti-G3BP to obtain 32P-G3BP as substrate for a phosphatase liquid assay. Wild-type pMT2-FLAG-MK-
STYX-FLAG and active mutant MK-STYX were expressed in HeLa cells, immunoprecipitated with anti-FLAG and assayed for phosphatase
activity against (A) 32P-G3BP or (B) 32P-G3BP-GFP immunoprecipitates as substrate. The active mutant dephosphorylated endogenous
G3BP-1, as well as G3BP-1-GFP. Three replicate experiments were performed. Error bars indicate the SEM. (C) An aliquot of the anti-FLAG
immunoprecipitate (IP) used in the assays was resolved by SDS/PAGE and analyzed. Blots (IB) were probed with anti-FLAG to visualize
immunoprecipitated MK-STYX, confirming the presence of wild-type and active mutant MK-STYX in the phosphatase assays. (D) HeLa cells
expressing MK-STYX or MK-STYXactive were lysed and resolved by SDS/PAGE and analyzed. Blots were probed with anti-phosphoG3BP149
to determine the phosphorylation status of G3BP-1 at Ser149, anti-FLAG to confirm the presence of MK-STYX and b-tubulin as a loading
control.
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member of the MAPK phosphatase class of PTPs,
which regulates downstream MAPKS effectors of Ras
[31], provides another link for MK-STYX as a stress
regulator. In addition to MK-STYX acting as a
stress-linked regulator, a recent study suggested that
MK-STYX also acts as a gatekeeper to mitochondrial
cell death in the apoptotic pathway [32]. Thus,
MK-STYX may play a pivotal role in a number of
cell signalling pathways.
Our results demonstrate that the phosphorylation
of G3BP-1 has different effects on MK-STYX and
MK-STYXactive. Furthermore, the active mutant
induces the assembly of intermediate-sized granules in
cells expressing phosphomimetic S149E-G3BP-1. In
the absence of MK-STYXactive, cells expressing S149E-
G3BP-1 do not exhibit elevated levels of stress granule
formation. This result suggests that the active mutant
causes a conformational change, independent of
dephosphorylation, that induces stress granule assem-
bly. The N-terminus of G3BP-1 is characterized by the
presence of a nuclear transport factor 2 (NTF2)-like
domain, and a segment rich in acidic acids that has a
key role in protein–protein interactions [23]. Previous
studies showed that the Ser149 residue essential for
stress granule formation lies 20 amino acids upstream
of this NTF2 domain [23]. Furthermore, the NTF2
domain promotes G3BP-1 aggregation, which is pre-
vented when G3BP-1 is phosphorylated at Ser149 [23].
Perhaps the interaction of the wild-type pseudophospha-
tase MK-STYX with G3BP-1 causes a conformational
change in its binding partners that prevents the aggrega-
tion of the NTF2 domains of G3BP-1. This paradigm has
been reported with the pseudophosphatases EGG-4 and
EGG-5. Their interaction with the kinase MBK-2 pre-
vents accessibility to the kinase activation loop [15]. Fur-
thermore, EGG-4 and EGG-5 are able to bind theMBK-
2 YTY motif regardless of phosphorylation [15]. We
report similar data in the present study with the pseudo-
phosphatase MK-STYX, which inhibits stress granule
formation in the presence of G3BP-1 nonphosphorylated
or phosphorylatablemutants.
In conclusion, the data obtained in the present study
enhance our understanding of MK-STYX and its
effects on stress granule dynamics, offering insights into
G3BP-1-induced stress granule formation. Our data
provide evidence that MK-STYX prevents stress gran-
ule accumulation independently of G3BP-1 phosphory-
lation at site 149. It will be of interest to investigate the
dynamics between MK-STYX and G3BP-1 that result
in the inhibition of stress granules. For example, is the
role of MK-STYX in stress granule dynamics via poly-
some accumulation or stress granule disassembly?
The precise mechanism of the pseudophosphatase
MK-STYX still remains to be defined. However, our
results dispel the notion that pseudophosphatases serve
exclusively as ‘protectors’ that block protein tyrosine
phosphatases. Instead, they support a model in which
pseudophosphatases have very distinctive roles in regu-
lating phosphorylation cascades. Taken together, our
findings point toward a pivotal role of the pseudophos-
phastase MK-STYX as a bona fide modulator in the
stress response signalling pathway.
Experimental procedures
Plasmid constructs
pMT2-FLAG-MK-STYX-FLAG and pMT2-FLAG-MK-
STYXactive-FLAG were generated as described previously
by Hinton et al. [1]. The integrity of all constructs derived
from PCR was confirmed by DNA sequencing. The G3BP-
1-GFP, S149A-G3BP-GFP and S149E-G3BP-GFP con-
structs were kindly provided by Jamai Tazi (Institut de
Genetique Moleculaire, Montpellier, France).
A
B
C
D
E
Fig. 6. A model of the effects of MK-STYX or MK-STYXactive on
G3BP-1-induced stress granules. (A) Overexpression of G3BP-1
induces stress granules, which are inhibited by MK-STYX. (B)
MK-STYX inhibits stress granule formation by the G3BP-1
nonphosphorylatable mutant S149A-G3BP-1. (C) The phosphomi-
metic mutant S149E-G3BP-1 does not aggregate to form stress
granules. (D) Heat shock induces S149E-G3BP-1 stress granules,
although their formation is blocked by MK-STYX. (E) MK-STYXactive
induces stress granules.
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Cell culture and transient transfection
HeLa cells were maintained at 37 °C in 5% CO2 in MEM
(Invitrogen, Carlsbad, CA, USA) supplemented with 10%
fetal bovine serum. Transfections were performed using
Lipofectamine 2000 (Invitrogen). When heat shock experi-
ments were required, cells were maintained at 41 °C for 1 h
followed by immediate fixation or lysing for either immu-
noprecipitation or immunoblotting.
Transient transfection and cell imaging
For immunofluorescence assays, HeLa cells were grown to
80–90% confluence and 2 9 105 cells were plated onto cov-
erslips in six-well dishes (Nunc, Rochester, NY, USA).
Twenty-four hours post-plating, cells at 40–60% confluence
were transfected with 2 lg of G3BP-1, S149A-G3BP-GFP,
S149E-G3BP-GFP, pMT2, or wild-type or mutant FLAG-
tagged MK-STYX expression plasmid DNA and 4 lL of
Lipofectamine 2000 per well, in accordance with the manu-
facturer’s instructions. The medium was replaced 5 h after
transfection. Twenty-four hours post-transfection, cells
were washed with PBS and fixed with 3.7% formaldehyde.
The coverslips were mounted to a slide using GelMount
containing 4′,6-diamidino-2′-phenylinodole dihydrochloride
(DAPI; Sigma, St Louis, MO, USA) (0.5 mgmL1).
For experiments examining the effect of MK-STYX and
the active mutant on stress-induced stress granule assembly,
cells were transfected with S149A-G3BP-GFP or S149E-
G3BP-GFP and either pMT2, wild-type or mutant FLAG-
tagged MK-STYX expression plasmid DNA. The medium
was replaced 5 h after transfection and, at 23 h post-trans-
fection, cells were stressed at 41 °C for 1 h, and then pro-
cessed as above. For localization studies, cells were
transfected with pMT2, MK-STYX or MK-STYXactive. To
visualize stress granule assembly with cells expressing
MK-STYX or MK-STYXactive, endogenous G3BP-1 was
used as the marker and visualized with anti-G3BP (dilution
1 : 100) and Cy3 (indocarbocyanine)-conjugated goat anti-
mouse (dilution 1 : 200; Zymed Laboratories Inc., San
Francisco, CA, USA) sera. To visualize the localization of
MK-STYX or MK-STYXactive, anti-FLAG-fluorescein iso-
thiocyanate (FITC) (dilution 1 : 100; Sigma) sera was used.
Counting and image collection were performed on an
Olympus BX60 microscope with U-MNU filter cube for
DAPI and Omega Optical XF100-2 for GFP and an Olym-
pus 9 40 UPlanFL 9 40/0.75 objective (Olympus, Tokyo,
Japan). A Cooke SensiCam camera and IPLAB software
(Becton-Dickinson Biosciences, Franklin Lakes, NJ, USA)
were used for image acquisition and primary image pro-
cessing. IMAGEJ (NIH, Bethesda, MD, USA), ADOBE PHOTO-
SHOP and ADOBE ILLUSTRATOR (Adobe Systems, San Jose,
CA, USA) were used for secondary image processing.
Approximately 100 cells were scored per treatment. Sam-
ples were scored blind with respect to treatment and were
scored independently by two different individuals. Cells
were scored into two categories: no stress granules and
stress granules.
Metabolic labelling
Forty-eight hours after post-transfection with G3BP-1-
GFP, HeLa cells were incubated for 30 min in DMEM
minus phosphate (Invitrogen), supplemented with 10% dia-
lyzed fetal bovine serum and 1 : 100 L-glutamine. Subse-
quently, cells were incubated for 3 h in medium containing
1 mCi [c-32P]ATP, and tagged or endogenous G3BP-1 pro-
teins were immunoprecipitated from cell lysates with anti-
G3BP sera (Becton-Dickinson Biosciences). Samples were
eluted with 25 mM imidazole (pH 7.2), and used for the
protein phosphatase activity assay.
Assay of protein phosphatase activity
HeLa cells were transfected either with expression vectors for
native MK-STYX (pMT2-FLAG-MK-STYX-FLAG) or the
catalytically active mutant MK-STYX (pMT2-FLAG-MK-
STYXactive-FLAG). Forty-eight hours post-transfection,
cells were lysed and MK-STYX proteins were immunopre-
cipitated using anti-FLAG sera (Sigma). Phosphatase
activity in the immunoprecipitates was assayed by incubation
with 32P-labelled G3BP-1 or G3BP-GFP as the substrate at
30 °C in 25 mM imidazole (pH 7.2), 0.1 mgmL1 bovine
serum albumin and 1 mM dithiothreitol. G3BP-1 was
labelled by [c-32P]ATP and immunoprecipitated with anti-
G3BP (Becton-Dickinson Biosciences). The reaction was
terminated by the addition of a 300 lL charcoal mix (0.9 M
NaCl, 90 mM Na4P2O7, 2 mM NaH2PO4 and charcoal;
Sigma) followed by centrifugation and counting of 250 lL
supernatant in scintillant. The activity was determined with a
LS 6500 Multi-purpose Scintillation Counter (Beckman
Coutler, Inc., Fullerton, CA, USA). The presence of immu-
noprecipitated MK-STYX and the active mutant was
confirmed by 10% SDS/PAGE and autoradiography.
Immunoprecipitation and immunoblotting
Forty-eight hours post-transfection, HeLa cells were har-
vested in lysis buffer [50 mM HEPES, pH 7.2, 150 mM
NaCl, 10% glycerol, 10 mM NaF, 1% Nonidet P-40 alter-
native (Calbiochem, San Diego, CA, USA) and protease
inhibitor cocktail tablets (Roche, Basel, Switzerland)].
Lysates were centrifuged at 14 000 g for 10 min, and the
supernatant protein concentration was determined by
NanoDrop quantification (NanoDrop Technologies, Inc.,
Wilmington, DE, USA). For immunoprecipitation, the
lysates were precleared and incubated with anti-FLAG
(Sigma) or anti-G3BP (Becton-Dickinson Biosciences) for
1 h at 4 °C, followed by incubation with Protein G beads
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(GE Healthcare, Little Chalfont, UK). Samples were
washed three times in lysis buffer and boiled in Laemmli
sample buffer. Lysates were resolved by 10% SDS/PAGE
and transferred to a poly(vinylidene difluoride) membrane
(GE Healthcare) for immunoblot analysis with anti-FLAG
(Sigma) and anti-G3BP sera, followed by chemiluminescent
detection. 32P-labelled immunoprecipitates were eluted with
imidazole and stored for phosphatase analysis. For phos-
pho-G3BP studies, lysates were resolved by 10% SDS/
PAGE and transferred to a poly(vinylidene difluoride)
membrane with the iBlotter (Invitrogen) for immunoblot
analysis with anti-phoshoG3BP (pSer149) (Sigma), anti-
FLAG (Sigma) and b-tubulin (Pierce, Rockford, IL, USA)
sera. Blots were probed first with pSer149 (dilution
1 : 1000), and then b-tubulin for the loading control.
Aliquots of the same sample lysates were resolved simulta-
neously and probed for anti-FLAG.
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